Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  12/21/2010
 
Trade Name:  INOmax
 
Generic Name or Proper Name (*):  nitric oxide
 
Indications Studied:  Prevention of bronchopulmonary dysplasia
 
Label Changes Summary:  INOmax is not indicated for prevention of BPD in preterm neonates d 34 weeks gestational age.Efficacy for the prevention of BPD in preterm infants was not established in three ldouble-blind, placebo-controlled clinical trials in a total of 2,149 preterm infants Information on clinical trials, adverse reaction
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  INO Therapeutics
 
Pediatric Exclusivity Granted Date:  11/02/2010
 
NNPS:  FALSE'
 
Therapeutic Category:  Pulmonary vasodilator
 
-
-